Lipton A - Search Results

1

Oncobiology and treatment of breast cancer in young women.

Kumar R, Abreu C, Toi M, Saini S, Casimiro S, Arora A, Paul AM, Velaga R, Rameshwar P, Lipton A, Gupta S, Costa L. Kumar R, et al. Among authors: lipton a. Cancer Metastasis Rev. 2022 Sep;41(3):749-770. doi: 10.1007/s10555-022-10034-6. Epub 2022 Apr 30. Cancer Metastasis Rev. 2022. PMID: 35488982 Review.

2

Bone turnover markers: tools for prognosis and monitoring response to bisphosphonates?

Lipton A, Costa L, Coleman RE. Lipton A, et al. Breast Dis. 2011;33(2):59-69. doi: 10.3233/BD-2010-0327. Breast Dis. 2011. PMID: 22142664 Review.

3

N-Telopeptide of Type I Collagen Long-Term Dynamics in Breast Cancer Patients With Bone Metastases: Clinical Outcomes and Influence of Extraskeletal Metastases.

Ferreira AR, Alho I, Shan N, Matias M, Faria M, Casimiro S, Leitzel K, Ali S, Lipton A, Costa L. Ferreira AR, et al. Among authors: lipton a. Oncologist. 2016 Dec;21(12):1418-1426. doi: 10.1634/theoncologist.2015-0527. Epub 2016 Aug 17. Oncologist. 2016. PMID: 27534575 Free PMC article.

4

Cellular Fitness Phenotypes of Cancer Target Genes from Oncobiology to Cancer Therapeutics.

George B, Pillai PM, Paul AM, Amjesh R, Leitzel K, Ali SM, Sandiford O, Lipton A, Rameshwar P, Hortobagyi GN, Pillai MR, Kumar R. George B, et al. Among authors: lipton a. Cells. 2021 Feb 18;10(2):433. doi: 10.3390/cells10020433. Cells. 2021. PMID: 33670680 Free PMC article.

5

RANKL/RANK/MMP-1 molecular triad contributes to the metastatic phenotype of breast and prostate cancer cells in vitro.

Casimiro S, Mohammad KS, Pires R, Tato-Costa J, Alho I, Teixeira R, Carvalho A, Ribeiro S, Lipton A, Guise TA, Costa L. Casimiro S, et al. Among authors: lipton a. PLoS One. 2013 May 16;8(5):e63153. doi: 10.1371/journal.pone.0063153. Print 2013. PLoS One. 2013. PMID: 23696795 Free PMC article.

6

Prognostic factors for skeletal complications from metastatic bone disease in breast cancer.

Brown JE, Cook RJ, Lipton A, Costa L, Coleman RE. Brown JE, et al. Among authors: lipton a. Breast Cancer Res Treat. 2010 Oct;123(3):767-79. doi: 10.1007/s10549-010-0981-1. Epub 2010 Jun 24. Breast Cancer Res Treat. 2010. PMID: 20574672

7

Anticancer evidence for zoledronic acid across the cancer continuum.

Costa L, Harper P, Coleman RE, Lipton A. Costa L, et al. Among authors: lipton a. Crit Rev Oncol Hematol. 2011 Feb;77 Suppl 1:S31-7. doi: 10.1016/S1040-8428(11)70006-3. Crit Rev Oncol Hematol. 2011. PMID: 21353179 Review.

8

Lactoferrin-endothelin-1 axis contributes to the development and invasiveness of triple-negative breast cancer phenotypes.

Ha NH, Nair VS, Reddy DN, Mudvari P, Ohshiro K, Ghanta KS, Pakala SB, Li DQ, Costa L, Lipton A, Badwe RA, Fuqua S, Wallon M, Prendergast GC, Kumar R. Ha NH, et al. Among authors: lipton a. Cancer Res. 2011 Dec 1;71(23):7259-69. doi: 10.1158/0008-5472.CAN-11-1143. Epub 2011 Oct 17. Cancer Res. 2011. PMID: 22006997 Free PMC article.

9

Treatment of bone metastases before the onset of pain.

Costa L, Lipton A, Hadji P, Chen YM, Kosmidis P. Costa L, et al. Among authors: lipton a. Int J Clin Oncol. 2013 Jun;18(3):531-8. doi: 10.1007/s10147-012-0414-8. Epub 2012 May 11. Int J Clin Oncol. 2013. PMID: 22572805 Clinical Trial.

10

Impact of skeletal complications on patients' quality of life, mobility, and functional independence.

Costa L, Badia X, Chow E, Lipton A, Wardley A. Costa L, et al. Among authors: lipton a. Support Care Cancer. 2008 Aug;16(8):879-89. doi: 10.1007/s00520-008-0418-0. Epub 2008 Apr 8. Support Care Cancer. 2008. PMID: 18392862 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

508 results

Search Page